Zacks Investment Research cut shares of Abcam PLC (NASDAQ:ABCZY) from a hold rating to a sell rating in a research note released on Monday morning.

According to Zacks, “Abcam PLC distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays and other kits. Abcam PLC is headquartered in Cambridge, the United Kingdom. “

Shares of Abcam PLC (ABCZY) opened at 15.22 on Monday. The stock has a market capitalization of $3.08 billion and a P/E ratio of 59.45. Abcam PLC has a 1-year low of $9.13 and a 1-year high of $15.22. The stock’s 50 day moving average price is $14.06 and its 200-day moving average price is $12.45.

WARNING: This report was originally posted by Daily Political and is the sole property of of Daily Political. If you are accessing this report on another site, it was illegally copied and reposted in violation of US and international trademark and copyright law. The correct version of this report can be viewed at https://www.dailypolitical.com/2017/09/14/abcam-plc-abczy-cut-to-sell-at-zacks-investment-research.html.

Get a free copy of the Zacks research report on Abcam PLC (ABCZY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Abcam PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abcam PLC and related companies with MarketBeat.com's FREE daily email newsletter.